Blood disorders in portal vein blockage outside the liver
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This study looks at blood problems in people who have a blockage in the main vein outside the liver (called extrahepatic portal vein obstruction). It aims to understand how this condition affects blood counts and clotting, which could help with future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with extrahepatic portal vein obstruction (a blockage in the main vein that carries blood from the intestines to the liver, located outside the liver)
- Your liver function is still preserved (not severely damaged)
- You have complete medical records including blood counts, liver function tests, and clotting tests
- You do not have cirrhosis (advanced liver scarring) or high blood pressure in the veins inside the liver
- You do not have a blood cancer or are not currently on chemotherapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a minimally invasive procedure to restore blood flow in children with a blocked portal vein (the major vein carrying blood from the intestines to the liver). It aims to reduce complications like bleeding from enlarged veins in the stomach or esophagus, an enlarged spleen, or fluid buildup in the belly.
This study observes patients with blood clotting or bleeding disorders over time to collect health information and improve care.
This study looks at a new way to predict if patients with blood cancers and very low platelets will have bleeding problems. By doing extra blood tests, researchers hope to create a score that helps doctors prevent bleeds.
This study is following people with cirrhosis to see how often they get a blood clot in the liver's main vein (portal vein) and whether using blood thinners helps. If you have cirrhosis, joining this study could help doctors learn better ways to prevent and treat these clots.
This study looks at how blood clots in the portal vein (the main vein to your liver) affect recovery and outcomes after a liver transplant. If you've had a liver transplant, your data may help doctors understand this better.
This study looks at heart and blood vessel problems in people with certain blood cancers called myeloproliferative neoplasms (MPNs), including essential thrombocythemia, polycythemia vera, and primary myelofibrosis. It aims to understand how these conditions affect the heart and blood vessels, which may lead to better care.
Hear when a new Thrombophilia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.